Bupropion HCL ER   3

Background
The Defense Logistics Agency (DLA) Troop Support, Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers. As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule. The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government contracts. The awardee consents to allow VA and DLA Troop Support Prime Vendors to distribute the listed products in the schedule.

Work Details
Bupropion HCL ER 150 MG Tablet ER 24H – 30 Count, Bupropion HCL ER 150 MG Tablet ER 24H – 90 Count, Bupropion HCL ER 150 MG Tablet ER 24H – 500 Count, Bupropion HCL ER 300 MG Tablet ER 24H – 30 Count, Bupropion HCL ER 300 MG Tablet ER 24H – 90 Count, Bupropion HCL ER 300 MG Tablet ER 24H – 500 Count.
The complete order quantity shall be delivered to the PPV contractors within 15 calendar days after receipt of order.

Period of Performance
The contract resulting herein will be for a one year base period and include four option years for a maximum possible term of five years. The contract will not exceed five years.